The Impact of Intravascular Ultrasound on Femoropopliteal Artery Endovascular Interventions: A Randomized Controlled Trial.
Richard B Allan, Phillip J Puckridge, J Ian Spark...
https://pubmed.ncbi.nlm.nih.gov/35272779/Actively Recruiting
Led by Baylor Research Institute · Updated on 2026-07-09
350
Participants Needed
6
Research Sites
26 weeks
Total Duration
Researchers are evaluating whether using ultrasound imaging inside blood vessels during minimally invasive treatment of leg arteries improves outcomes for patients with symptomatic peripheral artery disease PAD classified as Rutherford class 2-5. This prospective, multicenter randomized controlled trial in the U.S. aims to compare clinical results between ultrasound-guided and standard angiography-guided interventions. The study is led by the Baylor Research Institute and focuses on lower extremity arterial disease affecting several specific artery locations. Participants will receive one of two treatments either intravascular ultrasound IVUS guidance during their endovascular intervention or a standard angiographic-guided procedure without IVUS. The IVUS is used before and after procedures like atherectomy, balloon angioplasty, or stent placement to guide treatment. The trial follows participants through these treatments to assess outcomes over time. During the study, participants will be monitored for clinical success and functional improvements using questionnaires and classifications over 12 months, with primary patency assessed at 6 months. Researchers will also evaluate technical and procedural success during the initial procedure, survival without amputation, the need for repeat interventions, and cost effectiveness. The total study duration extends to July 2028, with ongoing assessments to measure the impact of ultrasound guidance on treatment results.
CONDITIONS
Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries
S
Sarah Hale
S
Sarah Weideman
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Baylor Research Institute
Lead Sponsor
Philips Healthcare
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | IVUS-Guided Intervention | Angiography-Guided Intervention |
|---|---|---|
| What it is | A combination of atherectomy, balloon angioplasty, and/or stent placement with guidance from intravascular ultrasound (IVUS) before and after the procedure to optimize treatment of narrowed lower extremity arteries. | Atherectomy, balloon angioplasty, and/or stent placement guided solely by standard angiographic imaging, without the use of IVUS, for the same narrowed arteries. |
| Role in the trial | Evaluated as an investigational approach to guide and optimize lower limb endovascular interventions. | Serves as the comparator arm representing the standard guiding approach currently used in clinical practice. |
| Primary use | To provide real-time visualization and measurement of the inside of arteries during and after peripheral interventions in order to improve precision in treating arterial blockages. | To use standard contrast-based X-ray imaging for identifying and treating arterial narrowing in the lower extremity. |
| How it is given or performed | During the procedure, a miniature ultrasound probe on a catheter is inserted into the artery. IVUS imaging is performed before and after the selected intervention (atherectomy, balloon angioplasty, or stent placement) to optimize results. | Contrast dye is injected, and X-ray imaging is used in real time to visualize the arteries before, during, and after intervention to guide the procedures. |
| Evidence status | Multiple randomized controlled trials and meta-analyses have evaluated IVUS-guided interventions. Evidence suggests potential improvements in technical success and primary patency compared to angiography, but further RCT evidence is ongoing. | Angiography-guided interventions reflect established practice and are supported by a substantial evidence base; however, newer studies are evaluating if outcomes can be further improved with adjunctive IVUS. |
| Important limitations | IVUS adds procedure time and cost; access to IVUS and operator experience may vary between centers. Some studies show conflicting results regarding long-term benefit, and routine use is not included in all guidelines. | Angiography offers less detailed imaging of vessel wall structure and may underestimate lesion severity or stent deployment issues. It provides limited information compared to intravascular imaging. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 12 months
Participants receive either intravascular ultrasound-guided or standard angiography-guided endovascular intervention for their leg artery lesions.
Duration - 12 months
Participants are monitored for clinical outcomes including artery openness, functional status, and survival without amputation for up to 12 months after treatment.
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Richard B Allan, Phillip J Puckridge, J Ian Spark...
https://pubmed.ncbi.nlm.nih.gov/35272779/Jae-Sik Jang, Han-Young Jin, Young-Ah Park...
https://pubmed.ncbi.nlm.nih.gov/39674438/Jennifer A Rymer, Eric A Secemsky
https://pubmed.ncbi.nlm.nih.gov/37071719/Jonghu Shin, Chul-Min Ahn, Seung-Jun Lee...
https://pubmed.ncbi.nlm.nih.gov/40792582/Sanjay Divakaran, Sahil A Parikh, Beau M Hawkins...
https://pubmed.ncbi.nlm.nih.gov/36265940/Wenzhuo Meng, Julong Guo, Dikang Pan...
https://pubmed.ncbi.nlm.nih.gov/37688486/Hywel Soney, Akash Kakkilaya, David Fernandez Vazquez...
https://pubmed.ncbi.nlm.nih.gov/37210800/Seung-Jun Lee, Tae-Hoon Kim, Jae-Hwan Lee...
https://pubmed.ncbi.nlm.nih.gov/39846915/Baylor Research Institute
Lead Sponsor
Philips Healthcare
Collaborating Sponsor